Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Shattuck Labs, Inc. STTK

Full chart Compare

Set alert

4.85 USD -0.14 (-2.81%)

At closeNov 10, 2026, 4:00 PM EST

4.85 0.00 0.00%

After hours · Nov 10, 4:00 PM ET

4.79 Day range 5.10

1.72 52-week range 8.33

YTD: +32.88%
1 year: +156.61%

News

5 days ago globenewswire.com Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights – Initiated the RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in Crohn's disease; 12-week induction data expected in the first half of 2028 – – Announced RECEPTIVE-HS1 Phase 2 clinical trial of…
4 weeks ago benzinga.com UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17 UBS analyst Alice Nettleton initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Buy rating and announces Price Target of $17.